Closed Loop Polarimetric Glucose Sensing Using The Pockels Effect

Author(s):  
King ◽  
Cote
Sensors ◽  
2017 ◽  
Vol 17 (8) ◽  
pp. 1723 ◽  
Author(s):  
Wei Deng ◽  
Hui Li ◽  
Chunxi Zhang ◽  
Pengjie Wang

2014 ◽  
Vol 32 (5) ◽  
pp. 1006-1013 ◽  
Author(s):  
Hui Li ◽  
Liyang Cui ◽  
Zhili Lin ◽  
Lijing Li ◽  
Chunxi Zhang

2009 ◽  
Vol 3 (5) ◽  
pp. 1014-1021 ◽  
Author(s):  
Daniela Bruttomesso ◽  
Anne Farret ◽  
Silvana Costa ◽  
Maria Cristina Marescotti ◽  
Monica Vettore ◽  
...  

New effort has been made to develop closed-loop glucose control, using subcutaneous (SC) glucose sensing and continuous subcutaneous insulin infusion (CSII) from a pump, and a control algorithm. An approach based on a model predictive control (MPC) algorithm has been utilized during closed-loop control in type 1 diabetes patients. Here we describe the preliminary clinical experience with this approach. In Padova, two out of three subjects showed better performance with the closed-loop system compared to open loop. Altogether, mean overnight plasma glucose (PG) levels were 134 versus 111 mg/dl during open loop versus closed loop, respectively. The percentage of time spent at PG > 140 mg/dl was 45% versus 12%, while postbreakfast mean PG was 165 versus 156 mg/dl during open loop versus closed loop, respectively. Also, in Montpellier, two patients out of three showed a better glucose control during closed-loop trials. Avoidance of nocturnal hypoglycemic excursions was a clear benefit during algorithm-guided insulin delivery in all cases. This preliminary set of studies demonstrates that closed-loop control based entirely on SC glucose sensing and insulin delivery is feasible and can be applied to improve glucose control in patients with type 1 diabetes, although the algorithm needs to be further improved to achieve better glycemic control. Six type 1 diabetes patients (three in each of two clinical investigation centers in Padova and Montpellier), using CSII, aged 36 ± 8 and 48 ± 6 years, duration of diabetes 12 ± 8 and 29 ± 4 years, hemoglobin A1c 7.4% ± 0.1% and 7.3% ± 0.3%, body mass index 23.2 ± 0.3 and 28.4 ± 2.2 kg/m2, respectively, were studied on two occasions during 22 h overnight hospital admissions 2–4 weeks apart. A Freestyle Navigator® continuous glucose monitor and an OmniPod® insulin pump were applied in each trial. Admission 1 used open-loop control, while admission 2 employed closed-loop control using our MPC algorithm.


Author(s):  
Sandeep Mariserla ◽  
Zayd Leseman ◽  
Thomas J. Mackin

Self-monitoring of blood glucose has become an important and critical tool for effective management of diabetes. A closed-loop, real-time sensing and dispensing system, however, has been elusive. We describe here, a novel MEMS-based sensor intended to measure, in realtime, the concentration of glucose in a solution. The device utilizes a bi-material membrane with a functional hydrogel layer that swells reversibly, and in proportion to, the presence of glucose. The hydrogel is composed of 2-hydroxyethyl methacrylate (HEMA) functionalized with 3-acrylamidophenylboronic acid (AAPBA) groups as the glucose-sensitive moiety. Phenylboronic acid (PBA) derivatives interact with glucose by forming a charged complex, causing the hydrogel to swell by solvent intake [1].


2010 ◽  
Author(s):  
Eun-Joo Park ◽  
Jacob Werner ◽  
Devina Jaiswal ◽  
Nadine Barrie Smith ◽  
Kullervo Hynynen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document